Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Robert Bonakdar MD, FAAFP, FACN Advisory Board

Dipesh Navsaria MPH, MSLIS, MD Advisory Board

Tricia C. Elliott MD, FAAFP Associate Editor

See All Experts

featured

Published in Primary Care and

Journal Scan / Research · August 01, 2024

Effects of Sleep Patterns on Risk of Chronic Disease

Nature Medicine

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Disclosure statements are available on the authors' profiles:

Peter Lin MD, CCFP

Timothy Overton MD, MPH

Nature Medicine

Sleep patterns and risk of chronic disease as measured by long-term monitoring with commercial wearable devices in the All of Us Research Program

Nat. Med. 2024 Jul 19;[EPub Ahead of Print], NS Zheng, J Annis, H Master, L Han, K Gleichauf, JH Ching, M Nasser, P Coleman, S Desine, DM Ruderfer, J Hernandez, LD Schneider, EL Brittain

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Effects of Sleep Patterns on Risk of Chronic Disease

Additional Info

Sleep patterns and risk of chronic disease as measured by long-term monitoring with commercial wearable devices in the All of Us Research Program

Further Reading

Light-to-Moderate Wine Consumption Tied to Lower Cardiovascular Disease Risk

Respiratory Benefits of Multisetting Air Purification in Children

Prophylaxis Options in Children With a History of Recurrent Urinary Tract Infections

Patient Hospitalized in Louisiana With First U.S. Case of Severe Bird Flu

Treatment of Restless Legs Syndrome and Periodic Limb Movement Disorder

Association of Children's Electronic Media Use With Physical Activity, Cognitive Function, and Stress

Association of Chocolate Intake With Risk of Type 2 Diabetes

Orthostatic and Standing Hypertension and Risk of Cardiovascular Disease

Potential Off-Label Indication of Metformin for Ischaemic Stroke

GLP-1 Agonists Combined With GIP and/or GCG Agonists vs GLP-1 Agonists Alone for Weight Loss in Adults With Obesity Without Type 2 Diabetes

Twofold More Cardiovascular Disease Events Decades Before Type 2 Diabetes Diagnosis

Recently Updated